The US Pharmacopeia (USP) has published its 2024-2025 Vulnerable Medicines List for the US, cataloguing “a data-based approach to identify risks and enable interventions to increase reliability of supply’.
The US Pharmacopeia (USP) has published its 2024-2025 Vulnerable Medicines List for the US, cataloguing “a data-based approach to identify risks and enable interventions to increase reliability of supply’.